Corvese Brian

Corvese Brian is listed in filings as Director at MiNK Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including 14 public disclosures. Recent filings connect the profile to MiNK Therapeutics, Inc. (INKT) and Agenus Inc. (AGEN). The current snapshot covers public activity from Jun 18, 2024 to Jun 2, 2026. Reported amounts are shown as $17.9K to $60.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.